Studies have shown that patients with KIRC have typical characteristics of immunogenic tumors, and TIICs in KIRC, including CD4 T cells, CD8 T cells, natural killer molecules, and dendritic cells, are inhibited to varying degrees, leading to antitumor immune disorders and successful evasion of immune recognition [44]. Here, CD8A is linked to immune system disorder.